Source and scope
This summary is bounded to the recommendations, population and decisions covered by Clinical Practice Guideline for the Management of Irritable Bowel Syndrome. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CAG IBS
Source-attributed clinical priorities
- Make a positive symptom-based diagnosis after targeted assessment for alarm features and important mimics.
- Avoid indiscriminate colonoscopy and food-allergy testing in a low-risk patient who meets the diagnostic pathway.
- Individualize diet, soluble fibre, gut-directed medication and psychological therapy by dominant symptoms and preference.
- Make a positive diagnosis after focused assessment rather than describing IBS only as a diagnosis of exclusion.
sources for this section:CAG IBS
Practical assessment and management workflow
1
Define pain relation to defecation, stool frequency and form, bloating, duration and dietary triggers.
2
Check blood, weight loss, nocturnal symptoms, fever, family history and inflammatory or celiac risk.
3
Use limited blood, stool or celiac testing appropriate to the phenotype and avoid broad untargeted panels.
4
Trial one diet, fibre, medicine or psychological intervention at a time and measure dominant-symptom response.
sources for this section:CAG IBS
Safety, red flags and urgent escalation
- Rectal bleeding, iron deficiency, mass, major weight loss or persistent nocturnal diarrhea needs investigation.
- Avoid a highly restrictive diet without dietitian support when nutrition or eating-disorder risk is present.
- Reassess a changing symptom pattern rather than attributing every future complaint to IBS.
sources for this section:CAG IBS
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CAG IBS
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CAG IBS
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Canadian Association of GastroenterologyClinical Practice Guideline for the Management of Irritable Bowel Syndromeaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.